Michael J. Detke, Chief Medical Officer at Cortexyme, Inc. (CRTX), sold 10,000 shares at $100.00 ($1.0M) on 2021-08-10, disclosed to the SEC on 2021-08-12.
Open-market sale of $1.0M CRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.